collection
MENU ▼
Read by QxMD icon Read
search

Bajose64

shared collection
14 papers 0 to 25 followers
https://www.readbyqxmd.com/read/27840364/25-years-of-proton-pump-inhibitors-a-comprehensive-review
#1
REVIEW
Daniel S Strand, Daejin Kim, David A Peura
Proton pump inhibitors (PPIs) were clinically introduced more than 25 years ago and have since proven to be invaluable, safe, and effective agents for the management of a variety of acid-related disorders. Although all members in this class act in a similar fashion, inhibiting active parietal cell acid secretion, there are slight differences among PPIs relating to their pharmacokinetic properties, metabolism, and Food and Drug Administration (FDA)-approved clinical indications. Nevertheless, each is effective in managing gastroesophageal reflux disease and uncomplicated or complicated peptic ulcer disease...
November 14, 2016: Gut and Liver
https://www.readbyqxmd.com/read/27007094/clinical-practice-guideline-management-of-acute-pancreatitis
#2
REVIEW
Joshua A Greenberg, Jonathan Hsu, Mohammad Bawazeer, John Marshall, Jan O Friedrich, Avery Nathens, Natalie Coburn, Gary R May, Emily Pearsall, Robin S McLeod
There has been an increase in the incidence of acute pancreatitis reported worldwide. Despite improvements in access to care, imaging and interventional techniques, acute pancreatitis continues to be associated with significant morbidity and mortality. Despite the availability of clinical practice guidelines for the management of acute pancreatitis, recent studies auditing the clinical management of the condition have shown important areas of noncompliance with evidence-based recommendations. This underscores the importance of creating understandable and implementable recommendations for the diagnosis and management of acute pancreatitis...
April 2016: Canadian Journal of Surgery. Journal Canadien de Chirurgie
https://www.readbyqxmd.com/read/26843915/gastroesophageal-reflux-disease-a-review-of-surgical-decision-making
#3
REVIEW
Maureen Moore, Cheguevara Afaneh, Daniel Benhuri, Caroline Antonacci, Jonathan Abelson, Rasa Zarnegar
Gastroesophageal reflux disease (GERD) is a very common disorder with increasing prevalence. It is estimated that up to 20%-25% of Americans experience symptoms of GERD weekly. Excessive reflux of acidic often with alkaline bile salt gastric and duodenal contents results in a multitude of symptoms for the patient including heartburn, regurgitation, cough, and dysphagia. There are also associated complications of GERD including erosive esophagitis, Barrett's esophagus, stricture and adenocarcinoma of the esophagus...
January 27, 2016: World Journal of Gastrointestinal Surgery
https://www.readbyqxmd.com/read/26600973/eosinophilic-esophagitis-from-pathophysiology-to-treatment
#4
REVIEW
Alessandra D'Alessandro, Dario Esposito, Marcella Pesce, Rosario Cuomo, Giovanni Domenico De Palma, Giovanni Sarnelli
Eosinophilic esophagitis (EoE) is a chronic immune disease, characterized by a dense eosinophilic infiltrate in the esophagus, leading to bolus impaction and reflux-like symptoms. Traditionally considered a pediatric disease, the number of adult patients with EoE is continuously increasing, with a relatively higher incidence in western countries. Dysphagia and food impaction represent the main symptoms complained by patients, but gastroesophageal reflux-like symptoms may also be present. Esophageal biopsies are mandatory for the diagnosis of EoE, though clinical manifestations and proton pump inhibitors responsiveness must be taken into consideration...
November 15, 2015: World Journal of Gastrointestinal Pathophysiology
https://www.readbyqxmd.com/read/26621548/the-management-of-antithrombotic-agents-for-patients-undergoing-gi-endoscopy
#5
Ruben D Acosta, Neena S Abraham, Vinay Chandrasekhara, Krishnavel V Chathadi, Dayna S Early, Mohamad A Eloubeidi, John A Evans, Ashley L Faulx, Deborah A Fisher, Lisa Fonkalsrud, Joo Ha Hwang, Mouen A Khashab, Jenifer R Lightdale, V Raman Muthusamy, Shabana F Pasha, John R Saltzman, Aasma Shaukat, Amandeep K Shergill, Amy Wang, Brooks D Cash, John M DeWitt
No abstract text is available yet for this article.
January 2016: Gastrointestinal Endoscopy
https://www.readbyqxmd.com/read/26690991/pitfalls-in-liver-imaging
#6
REVIEW
Valérie Vilgrain, Matthieu Lagadec, Maxime Ronot
Despite various sophisticated imaging techniques, there are numerous pitfalls in liver imaging. This review for residents discusses the major traps in image interpretation and gives some diagnostic clues to confidently interpret computed tomographic or magnetic resonance imaging studies.
January 2016: Radiology
https://www.readbyqxmd.com/read/26526079/acg-clinical-guideline-diagnosis-and-management-of-barrett-s-esophagus
#7
Nicholas J Shaheen, Gary W Falk, Prasad G Iyer, Lauren B Gerson
Barrett's esophagus (BE) is among the most common conditions encountered by the gastroenterologist. In this document, the American College of Gastroenterology updates its guidance for the best practices in caring for these patients. These guidelines continue to endorse screening of high-risk patients for BE; however, routine screening is limited to men with reflux symptoms and multiple other risk factors. Acknowledging recent data on the low risk of malignant progression in patients with nondysplastic BE, endoscopic surveillance intervals are attenuated in this population; patients with nondysplastic BE should undergo endoscopic surveillance no more frequently than every 3-5 years...
January 2016: American Journal of Gastroenterology
https://www.readbyqxmd.com/read/26378647/nonalcoholic-fatty-liver-disease-management-dietary-and-lifestyle-modifications
#8
REVIEW
Vi Nguyen, Jacob George
Nonalcoholic fatty liver disease (NAFLD) encompasses a spectrum of abnormalities that can range from bland liver fat (steatosis), to hepatic inflammation and liver injury (steatohepatitis). It is estimated that NAFLD will become the principal cause of liver disease in Western nations and the leading indication for liver transplantation. Advancements in disease recognition and management are therefore paramount. Although the development of new, reliable drug therapies is vital, lifestyle interventions remain the most effective treatment modality...
August 2015: Seminars in Liver Disease
https://www.readbyqxmd.com/read/26372826/treatment-of-helicobacter-pylori-infection-2015
#9
REVIEW
Anthony O'Connor, Javier P Gisbert, Colm O'Morain, Spiros Ladas
Many interesting articles have been published from many parts of the world over the last year assessing different issues around Helicobacter pylori eradication therapy. This article will address the published literature over the last year pertaining to the topic of treatment of H. pylori infection. The main themes that emerge are assessing the efficacy of standard triple therapy, as well as exploring new first-line treatments, mainly optimized nonbismuth- and bismuth-containing quadruple therapies with some promising data also emerging on dual therapy...
September 2015: Helicobacter
https://www.readbyqxmd.com/read/26341719/easl-clinical-practice-guidelines-autoimmune-hepatitis
#10
(no author information available yet)
No abstract text is available yet for this article.
October 2015: Journal of Hepatology
https://www.readbyqxmd.com/read/26219482/cirrhosis-a-practical-guide-to-management
#11
Raymond S Koff
No abstract text is available yet for this article.
July 25, 2015: Gastroenterology
https://www.readbyqxmd.com/read/26047908/expanding-consensus-in-portal-hypertension-report-of-the-baveno-vi-consensus-workshop-stratifying-risk-and-individualizing-care-for-portal-hypertension
#12
Roberto de Franchis
No abstract text is available yet for this article.
September 2015: Journal of Hepatology
https://www.readbyqxmd.com/read/24786095/molecular-mechanisms-and-new-treatment-strategies-for-non-alcoholic-steatohepatitis-nash
#13
REVIEW
Akinobu Takaki, Daisuke Kawai, Kazuhide Yamamoto
Non-alcoholic steatohepatitis (NASH) is a severe form of non-alcoholic fatty liver disease (NAFLD), in which most patients exhibit non-progressive, non-alcoholic fatty liver (NAFL) attributable to simple steatosis. Multiple hits, including genetic differences, fat accumulation, insulin resistance and intestinal microbiota changes, account for the progression of NASH. NAFLD is strongly associated with obesity, which induces adipokine secretion, endoplasmic reticulum (ER) and oxidative stress at the cellular level, which in turn induces hepatic steatosis, inflammation and fibrosis...
2014: International Journal of Molecular Sciences
https://www.readbyqxmd.com/read/17890258/hepatorenal-syndrome-current-diagnostic-and-therapeutic-concepts
#14
REVIEW
Michael Schepke
No abstract text is available yet for this article.
September 2007: Nephrology, Dialysis, Transplantation
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"